Aug 24 2026
 FDA Approval for Lupin’s Pitolisant Tablets

Posted at Aug 24 2026
h in News by

Just announced from Lupin Limited: Lupin Announces Approval from U.S. FDA for Pitolisant Tablets

Mumbai, Naples, August 17, 2026: Global pharma major Lupin Limited (Lupin) today announced that it has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.

Read the full release

Print page